Combination immune checkpoint inhibitors with platinum-based chemotherapy in advanced non-small cell lung cancer: what’s known and what’s next

Схожие документы

• Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors
  по: Qiao, Meng, et al.
  Опубликовано: (2018)
• Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
  по: Zhou, Fei, et al.
  Опубликовано: (2020)
• Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
  по: Ferrara, Roberto, et al.
  Опубликовано: (2021)
• Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
  по: Ferrara, Roberto, et al.
  Опубликовано: (2020)
• Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer
  по: Kuo, Chih‐Hsi Scott, et al.
  Опубликовано: (2019)